Captrust Financial Advisors Synlogic, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.63 - $2.55 $389 - $609	-239 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$2.45 - $4.1 $2,195 - $3,673	-896 Reduced 78.94%	239 $1,000
Q1 2021 May 17, 2021	BUY	$2.2 - $5.05 $297 - $681	135 Added 13.5%	1,135 $4,000
Q4 2020 Feb 16, 2021	BUY	$1.85 - $2.54 $1,850 - $2,540	1,000 New	1,000 $2,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.